PRE 14A

PRELIMINARY PROXY STATEMENT

Company: PharmaCyte Biotech, Inc.
Filed: July 19, 2023
Period of Report: August 31, 2023
Accession Number: 0001683168-23-004986

View Document ↗ View on SEC.gov ↗